当前位置：
X-MOL 学术
›
Arthritis Rheumatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Predictors of Rheumatic Immune-Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer
Arthritis & Rheumatology ( IF 13.3 ) Pub Date : 2021-08-16 , DOI: 10.1002/art.41949 Amy Cunningham-Bussel 1 , Jiaqi Wang 2 , Lauren C Prisco 2 , Lily W Martin 2 , Kathleen M M Vanni 2 , Alessandra Zaccardelli 2 , Mazen Nasrallah 3 , Lydia Gedmintas 1 , Lindsey A MacFarlane 1 , Nancy A Shadick 1 , Mark M Awad 4 , Osama Rahma 4 , Nicole R LeBoeuf 5 , Ellen M Gravallese 1 , Jeffrey A Sparks 1
Arthritis & Rheumatology ( IF 13.3 ) Pub Date : 2021-08-16 , DOI: 10.1002/art.41949 Amy Cunningham-Bussel 1 , Jiaqi Wang 2 , Lauren C Prisco 2 , Lily W Martin 2 , Kathleen M M Vanni 2 , Alessandra Zaccardelli 2 , Mazen Nasrallah 3 , Lydia Gedmintas 1 , Lindsey A MacFarlane 1 , Nancy A Shadick 1 , Mark M Awad 4 , Osama Rahma 4 , Nicole R LeBoeuf 5 , Ellen M Gravallese 1 , Jeffrey A Sparks 1
Affiliation
To identify predictors of rheumatic immune-related adverse events (irAEs) following immune checkpoint inhibitor (ICI) treatment for cancer.
中文翻译：
免疫检查点抑制剂治疗癌症后风湿性免疫相关不良事件和新发炎性关节炎的预测因子
确定免疫检查点抑制剂 (ICI) 治疗癌症后风湿免疫相关不良事件 (irAE) 的预测因子。
更新日期：2021-08-16
中文翻译：
免疫检查点抑制剂治疗癌症后风湿性免疫相关不良事件和新发炎性关节炎的预测因子
确定免疫检查点抑制剂 (ICI) 治疗癌症后风湿免疫相关不良事件 (irAE) 的预测因子。
京公网安备 11010802027423号